ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000719.1|Tobramycin_2 # 2523 # 3623 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.728	BGC0000719.1|Tobramycin_2 	2523	3623	+	Loose	1650	27.7202	Brucella suis mprF	27.18	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGTTTGGCGACGCGACCCTGCCCCTCGCTCCCGTCGCCACGCGTCCTTTGGTGTGCACGCCAGGACTTGGGGGTCGTCGCGTGAAGGCACTGACGTTCGTAGCGCCCGGCGAGGCGGTCTTCGGCACCCGCGCGGTGCCCGTCCCCGCCCCCGGTGAGGCGCTGGTCCGCCTCGGGTACAACTCGATCTGCGGCAGCGACCTGTCGCTGTACCGGGGCGTCTGGCACGGATTCGGCTACCCGGTCGTGCCGGGTCACGAGTGGAGCGGGACGGTCGTCGAGGTCAACGGGCCCGGCGACGAGTTGGTCGGCCGGGACGTGGTCGGCGACCTCACGTGCCCGTGCGGCGCGTGTGCCGCCTGTCAGCGCGGGACTCCGGTGCTCTGCGAGAACCTCCAGGAACTCGGGTTCACCCGGGACGGCGCGTGCGCGGAGTACATGACCATCCCGACGCGCAACCTGCACCGGCTGCCGGCGGAACTGTCGTTGCGGGTCGCCTGCCAGGTGGAGCCGGTCGCCGTTGCCCTGCACGCTCTGTCCACTGTGGACGTCTCGCCCGGGGAGAAGGTGGCCGTCCTCGGCGCCGGCGGGATCGGCCTGCTGTTGTCACAGGTGGCGCGACACCGGGGCGCGGTGATCACCACCGTCGGCGAGCCCGTCCCCGAGCGCAGGGCGGTCGCCGCCCAGCTCGGGGCGGCGACGGTGACGACCGGCCGCCCCGGCGAGCTGGCGGACCTGGTGGCCAAACGCCCGGAGCTGACCCCCGACGTCGTGCTGGAGGCCTCCGGCTACCCGGTCGCCCTGCAGGAGGCGATCGAGGTCGTGCGCCCCGGCGGCCGGATCGGCGTGGTGGGCTACCGGGTCGAGGAGATCAGCCCGATGGCGACCCACCACGTCGCCGTGAAGGCGTTGACGATCCGGGGCTCGCTGGGGCCCGGCAACCGGTTCCCCGACGCCATCGACCTGCTCGCTCGGCGCGAGATCAACGTCGATCCGCTGCTCAGCCACGAGTTCGCGCTGGCCGACCACGCCCGCGCGCTGGAGCTCGCGTTGCGCCGCACCGAGGGCAACATCCGCTCGTTCTTCAACCTCCGCGCCTGA	MFGDATLPLAPVATRPLVCTPGLGGRRVKALTFVAPGEAVFGTRAVPVPAPGEALVRLGYNSICGSDLSLYRGVWHGFGYPVVPGHEWSGTVVEVNGPGDELVGRDVVGDLTCPCGACAACQRGTPVLCENLQELGFTRDGACAEYMTIPTRNLHRLPAELSLRVACQVEPVAVALHALSTVDVSPGEKVAVLGAGGIGLLLSQVARHRGAVITTVGEPVPERRAVAAQLGAATVTTGRPGELADLVAKRPELTPDVVLEASGYPVALQEAIEVVRPGGRIGVVGYRVEEISPMATHHVAVKALTIRGSLGPGNRFPDAIDLLARREINVDPLLSHEFALADHARALELALRRTEGNIRSFFNLRA	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	41.59	gnl|BL_ORD_ID|2109|hsp_num:0	2281		
BGC0000719.1|Tobramycin_3 # 3733 # 5031 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.745	BGC0000719.1|Tobramycin_3 	3733	5031	+	Loose	800	41.5874	tetA(P)	26.58	3000180	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTCTCAGCATGCCGCGTCCGCAGACGAAACATCGGCCGGGGCGCCCGCCGCCGACCCGAGCCCCGAATCCCGGGCGCGGGCCAGGGCGACGGGCCGGCGACTGCGCCTGTTCTTCGGGCTGCACGAGCTGGTCCCGCTCTTCCCGCTCTACCCGCTGCTGTTCGCCGACCACGGGCTGTCCACCGCGGGGATCTCCGGGTTGCTGGCCCTCTGGTCGGTCACGGCCTTCGTCCTGGAGGTGCCCTCCGGGGTCCTGGGCGACATGTTCTCCCGCCGTTGGCTGCTCGCCGTCGGCACCGCCGTGCGGGCCTGCGGTTTCGGCCTGTGGGTGGCTTTCCCGTCGCCGTGGGCCTTCGCCGCCGGGTTCCTGTGCTGGGGCCTGTGCGACGCGCTGACCTCGGGAACGCTGGAGTCGCTGATCTACGACGAGCTGCGCGCGGCCGGCGCGTCCCACCGGTACGCGGCGGTGATGGGCAGCGGCCGGGCGGTGTCCCTGCTCTCCACGCTCACCGCGATGACGTTGGCCGGGCCGGTCTTCGCGCTCGGCGGCTACCCGCTCGTCGGGATGATCAGCCTGGGCAGCGGGCTGGCCTGCGCCGTCGCCGCGCTGCGGTTCTCCGAGCCGCCCCGGGACCAGGTCGGGCGGGAGGACGGCGGGTTGCGTTGGTACGTCGCGACCTTCCGGGCCGGGGTGTCGGAGGTGCGGCGGGACCGGGTGGTGCTGCGCGCGGTGCTCATCGCCGCGTCGCTGCACAGCATGACGGCCATCGACGAGTACTTCCCCATGCTGGCAAGGGCGAACGGCGCGTCGACGACGATGGTTCCGGTGCTGGTGGCCGTGACGGTCGTCTGCGCGGCGGCCGGCAGCGGTCTGGTCGGCAGGACCGCGCACGCCCCGCCCGCCGTGCTGGGCCTCGCCCTGCTGGCCTCGGCCGGGCTGATGGTGGCGGGCGCGCTGAGCGGGCTCCAGGCGGGCATGCTCGCCGTCGGGGTGAGCTTCGGCCTGGTGCAGTGGGCGCTGGTGCTGGCCGACACGCGGTTGCAGGACGCGATCACCGGTCCGGCGCGCGCGACCGTCACCTCGGTCGTCGGGTTCGGCGCCGAGGTGGCCTCGGTCGGCTTCTACCTGGGCGCCGGCGCTCTCTCCACCGTCACCTCCACGTCCGAGCTGTTGGCCTGGTTCGCGGTGCCGCTCGTCCTCATCGCGGTGGCCGCCCCGCGCTGGTTGAGACGGGAACCGCAGCCGCCCGGCGAGGTTCCCCGGGCGCCGGGAGCGGAACCACCGCGGCCTGCCTGA	MSQHAASADETSAGAPAADPSPESRARARATGRRLRLFFGLHELVPLFPLYPLLFADHGLSTAGISGLLALWSVTAFVLEVPSGVLGDMFSRRWLLAVGTAVRACGFGLWVAFPSPWAFAAGFLCWGLCDALTSGTLESLIYDELRAAGASHRYAAVMGSGRAVSLLSTLTAMTLAGPVFALGGYPLVGMISLGSGLACAVAALRFSEPPRDQVGREDGGLRWYVATFRAGVSEVRRDRVVLRAVLIAASLHSMTAIDEYFPMLARANGASTTMVPVLVAVTVVCAAAGSGLVGRTAHAPPAVLGLALLASAGLMVAGALSGLQAGMLAVGVSFGLVQWALVLADTRLQDAITGPARATVTSVVGFGAEVASVGFYLGAGALSTVTSTSELLAWFAVPLVLIAVAAPRWLRREPQPPGEVPRAPGAEPPRPA	MVNKLSAYKTYLLFSAITAMCFSLVATVMMVYHIEIVHLNPLQLILVGTTLELACFIFEIPTAIVADVYSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWIAEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLYMPENNFKPSAPGDLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNAHFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINILYISSMLIFALTRNFSLMLIAYLATNTFRIINKPIFSAWLNGHIDDNSRATVLSINGQMNSLGQILGGPIIGIIATNISVSIGIVCTSLLVTPVLVLYIVAMIIDKKVDDRVGGIDYEENN	102.86	gnl|BL_ORD_ID|477|hsp_num:0	508		
BGC0000719.1|Tobramycin_4 # 5208 # 6395 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.711	BGC0000719.1|Tobramycin_4 	5208	6395	+	Loose	275	25.7942	AAC(6')-Iaa	32.0	3002571	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGACCCAGACCAACGAGATCAGCGCGACGACGGGGGACTGGAGCCGGTCCGCCGAGCACCTGCGCCGGTCCCACGAGGTCACCACCAACCCCCGTCCCGACCAGGACGGCCAGTTCCCCTGCGTGCTCTCCAGGGGCGCGGGGGCGCGCGTGTACGACCTGGACGACAACGCCTACTTCGACCTCACCTGCTCGTTCGGCACCGTCCTCATCGGACACGCCGAGCCGGCCGTCACCGACGCGATCCGGGCGAGCCTGGACGACGGGAACCTGTTCTACACCGGGCCGAGCCCGCGCCGGCTCGCGCTGGCCGAACGCCTGCTCGACTGGTTCCCCTGGGCCGACCAGGCGTTGTTCTACCGGACCGGGTCCTGCGCGGTCTCCGCGGTCGCCCGGCTCACCCAGCACGTCACCGGCCGGACGACCGTGCTCACCTCGGGCTACCACGGCTGGCATGACTGGCACCTGGAGGCGGTGCCGGAGGCCAAGCTGTTCCCGTCCTACGCCACCGAGTTCCACGAGGACCTCGACGTCTACCGCGCCTACCTGGAGCGGCACGCGGACGAGATCGCCGCCGTGGTCGTCACGCCGGAGCCCACGCGGAAACCGGTGGGCCACTACCGCGTTCTGCGCGAGCTGGCCGCCGAGCACGGCTGTCTGTTCGTGGTGGACGAGGTGAAGACGGGCATGCGCGCGGGGAAGGGCGGGCTCAGCGCCCTCGCCGGGCTGGAACCGGACGCGGTGACCGTCTCCAAGGGACTGGCCAACGGGCACAGCATCTCCGCCGTGGTGGGCAGCCGCCGGATCACCGACGGCCTCGACGAGGCCCACGTGTGGTCCACGTACCAGAACGAGCAGGTGGGCTTCGCCGCCGCACTGGCCACTGTGGACTTCCTGGAGAGCCAGGACGTGGCCGCGGTCGTCGGACGCACGGGACGCGTGGTGGAGCAGGCGTTCCGGAGCGCGTTCGCCGAACGGGGCCTCCCGGTGGAGGTGCGCGGCTGGGGCCCGATGTTCGACCTCGACTTCTCCGCTGCCGAGGAGGGACTGGCCGACCGCCTGCAACTCGCCTTCCTCCGCCACGGCGTCTTCTGCGACATCGGCGACGACTTCAACGTCATGTACCGCACCGCCGACCACCTCGACGAGCTGACCGGGCGGGTGACCGCGGCGATCAGGTCGGTCTGA	MTQTNEISATTGDWSRSAEHLRRSHEVTTNPRPDQDGQFPCVLSRGAGARVYDLDDNAYFDLTCSFGTVLIGHAEPAVTDAIRASLDDGNLFYTGPSPRRLALAERLLDWFPWADQALFYRTGSCAVSAVARLTQHVTGRTTVLTSGYHGWHDWHLEAVPEAKLFPSYATEFHEDLDVYRAYLERHADEIAAVVVTPEPTRKPVGHYRVLRELAAEHGCLFVVDEVKTGMRAGKGGLSALAGLEPDAVTVSKGLANGHSISAVVGSRRITDGLDEAHVWSTYQNEQVGFAAALATVDFLESQDVAAVVGRTGRVVEQAFRSAFAERGLPVEVRGWGPMFDLDFSAAEEGLADRLQLAFLRHGVFCDIGDDFNVMYRTADHLDELTGRVTAAIRSV	MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADASIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPENTISQKVHQALGFEETERVIFYRKRC	272.41	gnl|BL_ORD_ID|1435|hsp_num:0	1526		
BGC0000719.1|Tobramycin_5 # 6448 # 7974 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.726	BGC0000719.1|Tobramycin_5 	6448	7974	+	Loose	1800	28.8758	mexY	31.75	3003033	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; acridine dye; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGCTGATCTCACCGGACGAGGCCGCGCGTCGGACCTACGACGCCTGTGTCATCGGCAGCGGCGCCTCCGGCTCCGTGGCCGCGGCCGTGCTCGCCGAGCGCGGTCTGTCGGTGCTCGTGGTGGAACAGGGCGGCCCGATCCCGCCGGGCGCCGACGGGGAGGACCACGAGGACCCCGACGGGTGGGCGTTCGCGCGCCGCGACGGGCGCTGGACCCGGGACGGCTACCCGTGGACGGCCATGGCGCTCGGCGGGGGAACCCTGTTCTACGCCGGGATGTCCTACCGCTACCAGCAGACCGACCTGGCCCCGCCCTCGTCGTTCCTCGGCGCCGCCGACTACGACCACTGGCAGGTCGGCCTCGCCGACCTCGAACCGCACTACGAGTGGATCGAGTACCAGCTCGCGATCGCCGGCCCCTCCAGGAAACAGGTGGGCGACTACGTCTTCCCCGTCTACCACCGGCCGAGCCTGCCGCTCACGCCGCCCGGCGCGGCGCTGGCCGAGGGCGCTCGCTCGCTCCACCTCACGCCCCTGCCCACCCCGGTGGCGATCAGCGGGGTGCGGGACCGGTTCGGCCCCGGCTGCGCCCAGACCACCCCGTGCACCTCGTTCTCCTGTCCCACGAAGGCCAAGGCCGACGTCGTCAGCCGGGTTCTCGCTCCCGCCGAGGGAGACGTCTCGGTGGTCGTCCACACCAGAGTCGTCCGGCTCGTGGCGTCGAGTCCGCACCGGGTTGACGCGGTCGAGGTGCTCGACCGCGAGAACGGCACGCGCCTGACCCTGCGCGCCCGTCGATTCCTGTTGGCCGCCAACGCGATCCAGTCCGCCGCGCTGCTGCTCCGGTCGACAACCCGCACCGAGCCGGACGGGATCGGCAACCGGCACGGGCTCGTCGGGCGGCACCTCGCGATGAAGAACAGCGTGTACGTGCGCGGGACCATCCCGCGCAGACTGCCCGGGTACACCCCGTTGCGACACCGGTACTCCAGCGTCTGCGTGTTGGACTTCCTCACCGGAGAAGCGTTTCCCGACGGAATCGGCGGACTGATCCACGAGGCCAACCCGTGGGAGCCCGCCGCCGAGCGGGAGGCGGCCCGCGGCACCCTGTTGCAGGTCGAGTGCCTGGTGGGCGACCGGCCCCAGGCCGAGAACCGGGTTCGGCTGTCCCGGACCCGGGACCGGGACGGCCTTCCCCGCATCGTCATGGACTACCGGCCGCACCCCGCCGACCTCCGGCGCTTGGCCGTGTTGTCCGAGCGCGCCCACGACATCCTCACCAAGGCCGGCGCCGTCGACGTGCGCGAGGTGGACACCGCCTACGAGTTGGGCAGCGCGCACCTGCACGGAACCCTGCGCGCCGGCCGAGACCCCCGCACGTCGGTGACCGACCCGTTCGGCCGCCTGCACGACCACGACAACGTCTGGTCGGTCGACGGCGCCACGTTCCCGTTCGCCGGCAACCCCAATCCCACCCTCACCATCCAGGCCAACGCCCACCGGATCGCGCTCGCGATCGACTGA	MLLISPDEAARRTYDACVIGSGASGSVAAAVLAERGLSVLVVEQGGPIPPGADGEDHEDPDGWAFARRDGRWTRDGYPWTAMALGGGTLFYAGMSYRYQQTDLAPPSSFLGAADYDHWQVGLADLEPHYEWIEYQLAIAGPSRKQVGDYVFPVYHRPSLPLTPPGAALAEGARSLHLTPLPTPVAISGVRDRFGPGCAQTTPCTSFSCPTKAKADVVSRVLAPAEGDVSVVVHTRVVRLVASSPHRVDAVEVLDRENGTRLTLRARRFLLAANAIQSAALLLRSTTRTEPDGIGNRHGLVGRHLAMKNSVYVRGTIPRRLPGYTPLRHRYSSVCVLDFLTGEAFPDGIGGLIHEANPWEPAAEREAARGTLLQVECLVGDRPQAENRVRLSRTRDRDGLPRIVMDYRPHPADLRRLAVLSERAHDILTKAGAVDVREVDTAYELGSAHLHGTLRAGRDPRTSVTDPFGRLHDHDNVWSVDGATFPFAGNPNPTLTIQANAHRIALAID	MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA	48.57	gnl|BL_ORD_ID|1687|hsp_num:0	1786		
BGC0000719.1|Tobramycin_6 # 8025 # 9737 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.722	BGC0000719.1|Tobramycin_6 	8025	9737	+	Loose	900	28.8758	adeH	28.0	3000779	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTGTCCTCGGACTGAACGGCTGGCCCCGCGACTTCCACGACGCGTCGGCGGCCCTGCTCGTCGACGGCCGGATCACGGCGTTCGCCGAGGAGGAGCGGTTCACCAGGAAGAAGCACGGGTACGACACGGCTCCCGCGCAGGCGGCGGCGTTCTGCCTGGCCCAGGCGGGCCTGACCGTGGACGACCTGGACGCCGTGGCCTTCGGCTGGGACCTGCCCAGGATGTACCGCGAGCGGCTGGGCGGCTGGCCGCACTCGGACAGCGAGGCGCTGGACATCCTGTTGCCCCGGCACCTCTTCCCCCGGCGCACCGACCCGCCGCTGCACTTCGTCCAGCACCACGTGGCGCACGCGGCCAGCGCCTACCACTTCTCCGGCGTCGACCACGGCGCGGTGCTGATCGTGGACGGCGAGGGCGAGGAGGAGTGCGTCACCCTGGCCCGGGCCGAGGGCGGGAAGATCACCGTGCTGGACACCGTCCCCGGTGCGTGGTCCCTGGGCTTCTTCTACGAGTCGGTCAGCGAGTACACCGGCCTGGGCGGCGAGAACCCCGGCAAGCTCATGGGACTGGCCGCGCACGGGACCGCGGCGGACGAGACGATGTCCACCTTCGCCTTCGAGCCGGACGGTTACCGGCTCGGCCTGCTCGACCCGGACGCGCGGGACCCGGAGGACTGGGACGAGTACTACCTGACGCAGCGGGCGTGGTTCGCGCACCTGGAGCGGACGTATCGCTTGCCCCCCAACGAGTTCGTCCACCGCTACGACCCCGCCAAGGGGCGGGTCGTGCGGGACACGCGACGGGACCCCTACGAGTACCGGGATCTGGCGGCCACCGCCCAGGCGGCGTTGGAGCGCGCGGTGTTCGGGCTGGCCGACTCGGTGCTCTCCCGCACGGGAGAGCGCAGTCTGTTCGTCGCAGGCGGTGTCGGTCTCAACGCGACCCTGAACGGCAAGCTGCTGACGCGGTCCACTGTGGACCACGTGTTCGTTCCCCCGGTGGCCAGCGACATCGGCGTGAGCCTCGGCGCGGCGGCGGTGGTCGCCGTCGAGCTCGGCGACCGCATCGCGCCCATGGGCGACACCGCCGCCTGGGGACCGGAGTTCTCCCCGGACCACGTGCGGGCCGCGCTCGACCGCACCGGCCTGTCCTACCGGGAGCCGGCCAACCTGGAGCGGGAGGTCGCCACGCTCGTCGCCGACGGCAAGGTGGTGGGCTGGGCGCAGGGCAGGGCCGAGGTCGGCCCGAGGGCGTTGGGCCAGCGCAGCCTGCTGGGCTCCGCGCACTCCCCGACCATGCGCGACCACATCAACCTGCGGGTCAAGGACCGGGAGTGGTGGCGTCCGTTCGCCCCCAGCATGCTGCGCTCGGTCAGCGACCAGGTGCTGGAGGTCGACGCCGACTTCCCCTACATGATCATGACGACGAAGGTGCGCGCGGCCTACGCCGAGCGCCTGCCGTCGGTGGTGCACGAGGACTGGTCGACCCGCCCGCAGACCGTGACCGAGGCCGGGAACCCGCGCTACCACCGGATGCTCACCGAGCTCGGCGACCTGGTCGGCGACCCGGTCTGCCTCAACACCTCCTTCAACGACCGGGGCGAACCCATCGTCTCGTCGCCGGCCGACGCCCTGCTCACCTTCGCCCGCCTGCCGATCGACGCCCTGGCCGTCGGCCCGTACCTGGTGACCAGGGACCTCCGCCACTAG	MRVLGLNGWPRDFHDASAALLVDGRITAFAEEERFTRKKHGYDTAPAQAAAFCLAQAGLTVDDLDAVAFGWDLPRMYRERLGGWPHSDSEALDILLPRHLFPRRTDPPLHFVQHHVAHAASAYHFSGVDHGAVLIVDGEGEEECVTLARAEGGKITVLDTVPGAWSLGFFYESVSEYTGLGGENPGKLMGLAAHGTAADETMSTFAFEPDGYRLGLLDPDARDPEDWDEYYLTQRAWFAHLERTYRLPPNEFVHRYDPAKGRVVRDTRRDPYEYRDLAATAQAALERAVFGLADSVLSRTGERSLFVAGGVGLNATLNGKLLTRSTVDHVFVPPVASDIGVSLGAAAVVAVELGDRIAPMGDTAAWGPEFSPDHVRAALDRTGLSYREPANLEREVATLVADGKVVGWAQGRAEVGPRALGQRSLLGSAHSPTMRDHINLRVKDREWWRPFAPSMLRSVSDQVLEVDADFPYMIMTTKVRAAYAERLPSVVHEDWSTRPQTVTEAGNPRYHRMLTELGDLVGDPVCLNTSFNDRGEPIVSSPADALLTFARLPIDALAVGPYLVTRDLRH	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	118.01	gnl|BL_ORD_ID|505|hsp_num:0	542		
BGC0000719.1|Tobramycin_7 # 9848 # 11122 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.736	BGC0000719.1|Tobramycin_7 	9848	11122	+	Loose	920	27.7202	OpmD	34.15	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCGTCCACCTCGCGATCAACAACGGAACCCCGGTGCGCACCCGGCCCTGGCCGGTCTGGCCCCAGCCGGCCCGGGGCGCGCTCGGCGCGCTGGAACGCGTGCTCCACTCCGGACGCTGGGCGATCAGCGGCCCCTACCGGGGCGCCGAGTCGGCCGAGCGCCGCTTCGCCAGGACCTTCGCCGCCTACAACGGGGTCGCGCACTGCGTCCCCGCGGCCAGCGGCACCGCCAGCCTCATGCTCGCGCTGGAAGCCTGCGGCGTTGGCGTCGGCGACGAGGTCATCGCCCCCGGACTGTCCTGGGTGGCCTCGGCCTCCACCATCGTCGGCGTCAACGCCGTCCCGGTCCTCGTCGACATCGACCCCGCGACCCTGTGCCTGGACCCGGCCGCGGTCGAGGCGGCGATCACGCCTGCCACCAGGGCGATCGTCGTCGTGCACCTGTACTCCGCGGTGGCCGACCTGGACGCGCTGCGCGGCGTCGCCGACCGGCACGGCCTGCCGCTGATCGAGGACTGCGCCCAGGCCCACGGCGCCGAACACCGCGGCCGTAAGGTCGGCTCGGTCGGCGACATCGGGACGTTCAGCATGCAGCACAGCAAGGTGCTCACCAGCGGGGAGGGCGGAGCCGCGATCACCGACTCCGCCGCGCTGGCCCGCAGGATGGAACACCTGCGCGCCGACGGCCGCTGCTATCCCGCCGCCGCGCCCGCGCCCGGACACATGGAACTGGTCGAGACCGGGGAGCTGATGGGCAGCAACCGGTGCCTGTCGGAGTTCCAGGCCGCCGTGCTCGTCGAGCAGCTCAGGGAACTCGACGAGCAGAACGCCCTGCGCCGTCGCAACGCCCTGCTGCTCAACGAGCTTCTCGCAGAGCAGGGGCTGCGGCCGCAGGACAGCTCGCCAGGCACCACCAGCCGCACGTACTACGTCTACGCCGCCGCCCTGCCCGACGACGCGCTGACCGACGTCCCGATCGCCGCCGTGACCGGGGCGCTCACCGCCGAGCTGGGCTTCCCGATCTCACCGGCCTACGCGCCACTGCACACCAACCGGCTCTACGCGCCGGCCTCCCGCCGCCGGTTCGCGCTCGGCGACGAGCACGAGAAGCGGATCGACCCCGGCCGGTTCCACCTGCCGGTGTGCGAGCGGCTCACCCGCCGCCTGATCACCTTCCACCACGCCGCGTTGCTCGGCGACGAGTCCGACGTGCGCGACATCGCCACCGCCGTCGCCAAGGTGCTGCGGCACCGCGGGGAGCTGCGGGCTTGA	MPVHLAINNGTPVRTRPWPVWPQPARGALGALERVLHSGRWAISGPYRGAESAERRFARTFAAYNGVAHCVPAASGTASLMLALEACGVGVGDEVIAPGLSWVASASTIVGVNAVPVLVDIDPATLCLDPAAVEAAITPATRAIVVVHLYSAVADLDALRGVADRHGLPLIEDCAQAHGAEHRGRKVGSVGDIGTFSMQHSKVLTSGEGGAAITDSAALARRMEHLRADGRCYPAAAPAPGHMELVETGELMGSNRCLSEFQAAVLVEQLRELDEQNALRRRNALLLNELLAEQGLRPQDSSPGTTSRTYYVYAAALPDDALTDVPIAAVTGALTAELGFPISPAYAPLHTNRLYAPASRRRFALGDEHEKRIDPGRFHLPVCERLTRRLITFHHAALLGDESDVRDIATAVAKVLRHRGELRA	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	87.06	gnl|BL_ORD_ID|410|hsp_num:0	442		
BGC0000719.1|Tobramycin_8 # 11152 # 12312 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.714	BGC0000719.1|Tobramycin_8 	11152	12312	+	Loose	700	28.1054	ADC-2	26.04	3003848	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase without carbapenemase activity	ATGCAGACCACCACCATCACCATGGGAGACGTCCACTACCCGTACCGGCTCGGCACCGGCTGCGTCGACGCGGTCGTCGACCGGCTGGGCGAGCTGGGCGCCAGCCACTACCTCGTGCTGTGCGACGCGACCGTCGCCGAGCTGTACGGGAATGACCTCGTCGCACGCCTGAACCGCGCGGCCGGGCCGGCCACCGTCCTGGTGCACCCGGCGGGGGAGGAGCACAAGGGGCTCGGCACGCTGAACACCCTCGCCGACGCCGCTCTCCACGCCGGAGTCGACCGGCGGGGACTGGTCGTCGCGCTGGGCGGCGGTGTCACCGGGAACATCGCCGGTCTGCTCGCCGCCCTGCTGTTCCGCGGGATTCGCCTGGTGCACGTGCCGACCACGGTCGTGGCGATGCTCGACTCGGTGCTGTCGTTGAAACAGGCCGTCAACGCCCAGGTGGGCAAGAACCTCGTCGGCACCTTCTACCCGCCGGTCGAGGTGCTCGCCGACACCGCGGTGCTGAACACCCTGCCGGTCAGGGAGATCCGGTCGGGGCTGTGCGAGGTCGTGAAGAACGCGTTGGCGATCCGGCCCAGCATGATCTCCTTCCTGGCCGCCGAGCTGCGACCCGACGGCCGCTACGCCGACGACGTCCTGCGCTGGATGATCGACGAGAGCATCGCGGCGAAGGCCCAGGTCACCGAGCACGACAAGTACGAGCGGCGGGAGGGCCTGGTCCTGGAGTACGGCCACACCGTCGGCCACGCCCTGGAACACGCCTCGCACGGCGCGGTGTCGCACGGCGCCGGCGTCGGGCTGGGAATGGTCGCCGCCGCCCGGGTTTCGCACCGCCTCGGGCACGTCGACGCCGGTTTCGCGGAGCTGCACCGGGAGTTGGTGAGCAAGGTCGGCGTCGCGACGACCGTGCCGACCAGCGTTCCGCACCAGGAGATCACCTACCGGCTCGGCTTCGACAACAAGCGGGGGTACCAGTCCCTCGCCGCCGACCAGTACGCGATGGTCCTGCTGGAGGGCGCTGGCCAACCGCTGCGCCGCGACGGCCTGCCACTGACACCGGTGCCCAGAGCCCTGGTCGACGAGGTCGTGCGGGAACTGGCCGGTGTCCCGTCGCGCGTCGGCGCGTCCGTCGCCACCGCGGGGGGTGCGTCGTGA	MQTTTITMGDVHYPYRLGTGCVDAVVDRLGELGASHYLVLCDATVAELYGNDLVARLNRAAGPATVLVHPAGEEHKGLGTLNTLADAALHAGVDRRGLVVALGGGVTGNIAGLLAALLFRGIRLVHVPTTVVAMLDSVLSLKQAVNAQVGKNLVGTFYPPVEVLADTAVLNTLPVREIRSGLCEVVKNALAIRPSMISFLAAELRPDGRYADDVLRWMIDESIAAKAQVTEHDKYERREGLVLEYGHTVGHALEHASHGAVSHGAGVGLGMVAAARVSHRLGHVDAGFAELHRELVSKVGVATTVPTSVPHQEITYRLGFDNKRGYQSLAADQYAMVLLEGAGQPLRRDGLPLTPVPRALVDEVVRELAGVPSRVGASVATAGGAS	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFINANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	100.78	gnl|BL_ORD_ID|2165|hsp_num:0	2335		
BGC0000719.1|Tobramycin_9 # 12309 # 12866 # 1 # ID=1_9;partial=01;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.742	BGC0000719.1|Tobramycin_9 	12309	12866	+	Loose	400	26.1794	vanRI	38.89	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGAGCGCGCCGCTGGGAGTCGCCGTGGTGGGCGCCGGGTTCATGGGCGGTGTCCACGCCGAAGTGCTCGCCGCGCACCCGCGTGCCCAGCTCGTCGCGGTCTGCGACCTCGACCAACGGGCCGCCCAGGAGTTGGCCGGGCGGTTCGCCGTTCCGACGGTCACCGACGACCTCGACCGCGTCCTGGCCGACGACCGGGTCGGCCTGGTGGTGGTGACGACCCCGAACGCGCTGCACGCCGACCAGGCGGCCCGGGCGTTGCGGGCCGGCCGACACGTGTTGGTCGAGAAACCCCTCGCCCTCACCCCGGACGAGATCCACGGGCTGCTGCGGCTGGCCACCGAGCGCGGCCTGGTGCTGGCGCACGGCAGCAACTTCGTGCAGAGCCCCAAGTTCCGCCGGGTTCGGGAACTGGTCGCCGACGCGGAGGCGTTCGGCACGCCCCACCTGGCCCGGGTCGTCGTGCGCAACGCGGGACCGGACTCCGGGTGGTGCCTGGACCCGGCGCTCGCCGGTGGGGGAGTGCTGCTCGATCTCGGTTGCCACGCCGTGGAGATC	MSAPLGVAVVGAGFMGGVHAEVLAAHPRAQLVAVCDLDQRAAQELAGRFAVPTVTDDLDRVLADDRVGLVVVTTPNALHADQAARALRAGRHVLVEKPLALTPDEIHGLLRLATERGLVLAHGSNFVQSPKFRRVRELVADAEAFGTPHLARVVVRNAGPDSGWCLDPALAGGGVLLDLGCHAVEI	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	80.17	gnl|BL_ORD_ID|2093|hsp_num:0	2246		
